Oscar Health (NYSE:OSCR) Price Target Cut to $11.00 by Analysts at Wells Fargo & Company

Oscar Health (NYSE:OSCR) had its price target cut by stock analysts at Wells Fargo & Company from $14.00 to $11.00 in a research note issued on Thursday,Benzinga reports. The brokerage currently has an “underweight” rating on the stock. Wells Fargo & Company‘s price target would suggest a potential downside of 22.79% from the company’s current price.

A number of other research analysts have also recently weighed in on the company. Baird R W cut Oscar Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 25th. Barclays raised their price target on Oscar Health from $11.00 to $13.00 and gave the company an “underweight” rating in a report on Monday. Wall Street Zen cut shares of Oscar Health from a “hold” rating to a “sell” rating in a research report on Saturday, August 9th. Zacks Research raised shares of Oscar Health from a “strong sell” rating to a “hold” rating in a research note on Monday, October 13th. Finally, UBS Group increased their price target on Oscar Health from $11.00 to $12.00 and gave the stock a “sell” rating in a report on Friday, November 7th. Six investment analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Reduce” and an average target price of $13.14.

Oscar Health Stock Down 5.7%

Shares of NYSE OSCR traded down $0.85 during mid-day trading on Thursday, hitting $14.25. 7,978,073 shares of the stock traded hands, compared to its average volume of 14,544,543. Oscar Health has a 52 week low of $11.20 and a 52 week high of $23.80. The stock has a fifty day moving average price of $19.04 and a 200-day moving average price of $16.87. The company has a market cap of $3.68 billion, a price-to-earnings ratio of -12.73 and a beta of 1.88. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.92 and a current ratio of 0.92.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.02. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The company had revenue of $2.93 billion during the quarter, compared to analyst estimates of $3.09 billion. During the same quarter last year, the company earned ($0.22) EPS. The firm’s revenue for the quarter was up 23.2% on a year-over-year basis. Oscar Health has set its FY 2025 guidance at EPS. Research analysts anticipate that Oscar Health will post 0.69 EPS for the current year.

Insider Activity

In other Oscar Health news, insider Mario Schlosser sold 395,000 shares of Oscar Health stock in a transaction dated Monday, September 22nd. The stock was sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the completion of the sale, the insider owned 501,148 shares of the company’s stock, valued at approximately $9,236,157.64. The trade was a 44.08% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 24.39% of the stock is currently owned by insiders.

Institutional Trading of Oscar Health

Several hedge funds and other institutional investors have recently bought and sold shares of OSCR. Victory Capital Management Inc. grew its stake in Oscar Health by 23.8% in the 1st quarter. Victory Capital Management Inc. now owns 285,997 shares of the company’s stock valued at $3,749,000 after acquiring an additional 54,938 shares during the period. Nuveen LLC purchased a new position in shares of Oscar Health during the 1st quarter worth approximately $29,684,000. NewEdge Advisors LLC boosted its stake in shares of Oscar Health by 89.7% in the first quarter. NewEdge Advisors LLC now owns 188,058 shares of the company’s stock valued at $2,465,000 after purchasing an additional 88,946 shares during the period. Matauro LLC acquired a new position in Oscar Health during the 2nd quarter worth $1,508,000. Finally, Connor Clark & Lunn Investment Management Ltd. raised its holdings in shares of Oscar Health by 19.0% in the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 501,972 shares of the company’s stock valued at $6,581,000 after purchasing an additional 79,979 shares in the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.